Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$0.58 - $1.3 $72,297 - $162,045
124,650 Added 67.12%
310,367 $319,000
Q1 2023

May 15, 2023

SELL
$1.09 - $1.82 $95,266 - $159,068
-87,400 Reduced 32.0%
185,717 $252,000
Q4 2022

Feb 14, 2023

BUY
$1.52 - $3.39 $209,152 - $466,464
137,600 Added 101.54%
273,117 $417,000
Q3 2022

Nov 15, 2022

BUY
$1.7 - $4.05 $11,758 - $28,013
6,917 Added 5.38%
135,517 $396,000
Q2 2022

Aug 15, 2022

SELL
$1.6 - $5.07 $61,440 - $194,688
-38,400 Reduced 22.99%
128,600 $238,000
Q1 2022

May 13, 2022

SELL
$3.92 - $5.86 $166,600 - $249,050
-42,500 Reduced 20.29%
167,000 $728,000
Q2 2021

Jul 30, 2021

BUY
$10.82 - $19.37 $915,372 - $1.64 Million
84,600 Added 67.73%
209,500 $3.43 Million
Q1 2021

May 06, 2021

BUY
$7.02 - $22.62 $473,850 - $1.53 Million
67,500 Added 117.6%
124,900 $2.39 Million
Q4 2020

Feb 08, 2021

BUY
$1.89 - $6.57 $14,931 - $51,903
7,900 Added 15.96%
57,400 $354,000
Q3 2020

Nov 12, 2020

SELL
$2.33 - $4.94 $236,029 - $500,422
-101,300 Reduced 67.18%
49,500 $145,000
Q2 2020

Aug 13, 2020

BUY
$2.17 - $5.35 $31,248 - $77,040
14,400 Added 10.56%
150,800 $644,000
Q1 2020

May 14, 2020

BUY
$1.57 - $3.85 $184,946 - $453,530
117,800 Added 633.33%
136,400 $349,000
Q4 2019

Feb 18, 2020

SELL
$3.09 - $4.69 $54,075 - $82,075
-17,500 Reduced 48.48%
18,600 $57,000
Q3 2019

Nov 14, 2019

BUY
$2.82 - $4.81 $27,636 - $47,137
9,800 Added 37.26%
36,100 $172,000
Q2 2019

Aug 14, 2019

BUY
$2.07 - $5.12 $27,323 - $67,584
13,200 Added 100.76%
26,300 $94,000
Q1 2019

May 14, 2019

SELL
$1.88 - $5.7 $41,924 - $127,110
-22,300 Reduced 62.99%
13,100 $27,000
Q4 2018

Feb 13, 2019

BUY
$3.02 - $9.2 $70,668 - $215,279
23,400 Added 195.0%
35,400 $118,000
Q2 2018

Aug 13, 2018

BUY
$5.03 - $7.06 $60,360 - $84,720
12,000 New
12,000 $77,000

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.